121 related articles for article (PubMed ID: 23553807)
1. Interleukin-21 in chronic inflammatory diseases.
Sarra M; Pallone F; Monteleone G
Biofactors; 2013; 39(4):368-73. PubMed ID: 23553807
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-21 as a new therapeutic target for immune-mediated diseases.
Monteleone G; Pallone F; Macdonald TT
Trends Pharmacol Sci; 2009 Aug; 30(8):441-7. PubMed ID: 19616319
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease.
Monteleone G; Pallone F; Macdonald TT
Cytokine Growth Factor Rev; 2009 Apr; 20(2):185-91. PubMed ID: 19261537
[TBL] [Abstract][Full Text] [Related]
4. IL-21 as a therapeutic target in inflammatory disorders.
Di Fusco D; Izzo R; Figliuzzi MM; Pallone F; Monteleone G
Expert Opin Ther Targets; 2014 Nov; 18(11):1329-38. PubMed ID: 25162763
[TBL] [Abstract][Full Text] [Related]
5. Role of IL-21 in inflammatory bowel disease.
Pallone F; Fina D; Caruso R; Monteleone G
Expert Rev Clin Immunol; 2010 Jul; 6(4):537-41. PubMed ID: 20594126
[TBL] [Abstract][Full Text] [Related]
6. Role of interleukin-21 in inflammation and allergy.
Fina D; Fantini MC; Pallone F; Monteleone G
Inflamm Allergy Drug Targets; 2007 Mar; 6(1):63-8. PubMed ID: 17352690
[TBL] [Abstract][Full Text] [Related]
7. Targeting interleukin-21 in inflammatory diseases.
Sarra M; Franzè E; Pallone F; Monteleone G
Expert Opin Ther Targets; 2011 Jun; 15(6):695-702. PubMed ID: 21391901
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-21 in immune and allergic diseases.
Sarra M; Cupi ML; Pallone F; Monteleone G
Inflamm Allergy Drug Targets; 2012 Aug; 11(4):313-9. PubMed ID: 22533549
[TBL] [Abstract][Full Text] [Related]
9. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-γ-dependent epidermal hyperplasia.
Sarra M; Caruso R; Cupi ML; Monteleone I; Stolfi C; Campione E; Diluvio L; Mazzotta A; Botti E; Chimenti S; Costanzo A; MacDonald TT; Pallone F; Monteleone G
J Immunol; 2011 May; 186(9):5435-42. PubMed ID: 21441456
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21: basic biology and implications for cancer and autoimmunity.
Spolski R; Leonard WJ
Annu Rev Immunol; 2008; 26():57-79. PubMed ID: 17953510
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-21 in T cell-mediated diseases.
Monteleone G; Sarra M; Pallone F
Discov Med; 2009 Oct; 8(42):113-7. PubMed ID: 19833056
[TBL] [Abstract][Full Text] [Related]
12. Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.
Ramanathan S; Dubois S; Chen XL; Leblanc C; Ohashi PS; Ilangumaran S
J Immunol; 2011 May; 186(9):5131-41. PubMed ID: 21430227
[TBL] [Abstract][Full Text] [Related]
13. IL-21: roles in immunopathology and cancer therapy.
Søndergaard H; Skak K
Tissue Antigens; 2009 Dec; 74(6):467-79. PubMed ID: 19845910
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 21 correlates with T cell and B cell subset alterations in systemic lupus erythematosus.
Terrier B; Costedoat-Chalumeau N; Garrido M; Geri G; Rosenzwajg M; Musset L; Klatzmann D; Saadoun D; Cacoub P
J Rheumatol; 2012 Sep; 39(9):1819-28. PubMed ID: 22859347
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and qualitative analysis of the balance between type 1 and type 2 cytokine-producing CD8(-) and CD8(+) T cells in systemic lupus erythematosus.
Amel-Kashipaz MR; Huggins ML; Lanyon P; Robins A; Todd I; Powell RJ
J Autoimmun; 2001 Sep; 17(2):155-63. PubMed ID: 11591124
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-35: Structure, Function and Its Impact on Immune-Related Diseases.
Ye C; Yano H; Workman CJ; Vignali DAA
J Interferon Cytokine Res; 2021 Nov; 41(11):391-406. PubMed ID: 34788131
[TBL] [Abstract][Full Text] [Related]
17. IL-17 immunity in human type 1 diabetes.
Honkanen J; Nieminen JK; Gao R; Luopajarvi K; Salo HM; Ilonen J; Knip M; Otonkoski T; Vaarala O
J Immunol; 2010 Aug; 185(3):1959-67. PubMed ID: 20592279
[TBL] [Abstract][Full Text] [Related]
18. Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases.
Tuller T; Atar S; Ruppin E; Gurevich M; Achiron A
Genes Immun; 2013 Mar; 14(2):67-82. PubMed ID: 23190644
[TBL] [Abstract][Full Text] [Related]
19. IL-21 in the pathogenesis and treatment of skin diseases.
Costanzo A; Chimenti MS; Botti E; Caruso R; Sarra M; Monteleone G
J Dermatol Sci; 2010 Nov; 60(2):61-6. PubMed ID: 20888735
[TBL] [Abstract][Full Text] [Related]
20. IL-35, an anti-inflammatory cytokine which expands CD4+CD25+ Treg Cells.
Castellani ML; Anogeianaki A; Felaco P; Toniato E; De Lutiis MA; Shaik B; Fulcheri M; Vecchiet J; Tetè S; Salini V; Theoharides TC; Caraffa A; Antinolfi P; Frydas I; Conti P; Cuccurullo C; Ciampoli C; Cerulli G; Kempuraj D
J Biol Regul Homeost Agents; 2010; 24(2):131-5. PubMed ID: 20487626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
